FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Nick Telford

Research Profile

Procedures

Fluorescence In Situ Hybridization

Anatomy

Disorders

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Christoph Walz; Michael Ritter; Joannah Score; Nick Telford; Adrian Bloor; Nicholas C P Cross; Philipp Erben; Stefan Gesk; Claudia Haferlach; Torsten Haferlach; Andreas Hochhaus; Wolf-Karsten Hofmann; Georgia Metzgeroth; Andreas Reiter
Response of ETV6-FLT3-positive myeloid/lymphoid neoplasm with eosinophilia to inhibitors of FMS-like tyrosine kinase 3.
Andreas Reiter; Christoph Walz; Ann Watmore; Claudia Schoch; Ilona Blau; Brigitte Schlegelberger; Ute Berger; Nick Telford; Shilani Aruliah; John A Yin; Danny Vanstraelen; Helen F Barker; Peter C Taylor; Aisling O'Driscoll; Fabio Benedetti; Cornelia Rudolph; Hans-Jochem Kolb; Andreas Hochhaus; Rüdiger Hehlmann; Andrew Chase; Nicholas C P Cross
The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2.
Alistair G Reid; Brian J P Huntly; Eveline Hennig; Dietger Niederwieser; Lynda J Campbell; Nick Bown; Nick Telford; Helen Walker; Colin Grace; Michael W N Deininger; Anthony R Green; Elisabeth P Nacheva
Deletions of the derivative chromosome 9 do not account for the poor prognosis associated with Philadelphia-positive acute lymphoblastic leukemia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Nick Telford (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Christoph Walz; Michael Ritter; Joannah Score; Nick Telford; Adrian Bloor; Nicholas C P Cross; Philipp Erben; Stefan Gesk; Claudia Haferlach; Torsten Haferlach; Andreas Hochhaus; Wolf-Karsten Hofmann; Georgia Metzgeroth; Andreas Reiter
Response of ETV6-FLT3-positive myeloid/lymphoid neoplasm with eosinophilia to inhibitors of FMS-like tyrosine kinase 3.
Blood 2011;118(8):2239-42.
2005: Andreas Reiter; Christoph Walz; Ann Watmore; Claudia Schoch; Ilona Blau; Brigitte Schlegelberger; Ute Berger; Nick Telford; Shilani Aruliah; John A Yin; Danny Vanstraelen; Helen F Barker; Peter C Taylor; Aisling O'Driscoll; Fabio Benedetti; Cornelia Rudolph; Hans-Jochem Kolb; Andreas Hochhaus; Rüdiger Hehlmann; Andrew Chase; Nicholas C P Cross
The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2.
Cancer research 2005;65(7):2662-7.
2002: Alistair G Reid; Brian J P Huntly; Eveline Hennig; Dietger Niederwieser; Lynda J Campbell; Nick Bown; Nick Telford; Helen Walker; Colin Grace; Michael W N Deininger; Anthony R Green; Elisabeth P Nacheva
Deletions of the derivative chromosome 9 do not account for the poor prognosis associated with Philadelphia-positive acute lymphoblastic leukemia.
Blood 2002;99(6):2274-5.
2001: Brian J P Huntly; Alistair G Reid; Anthony J Bench; Lynda J Campbell; Nick Telford; P Shepherd; J Szer; H M Prince; P Turner; Colin Grace; Elisabeth P Nacheva; Anthony R Green
Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia.
Blood 2001;98(6):1732-8.
2000: Gavin Cuthbert; K Thompson; S McCullough; Ann Watmore; Ho Dickinson; Nick Telford; F Mugneret; C Harrison; M Griffiths; Nick Bown
MLL amplification in acute leukaemia: a United Kingdom Cancer Cytogenetics Group (UKCCG) study.
Leukemia 2000;14(11):1885-91.
2000: PB Sinclair; Elisabeth P Nacheva; M Leversha; Nick Telford; J Chang; A Reid; Anthony J Bench; KM Champion; Brian J P Huntly; Anthony R Green
Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia.
Blood 2000;95(3):738-43.